申请人:——
公开号:US20040171125A1
公开(公告)日:2004-09-02
The invention relates to a process for the preparation of a 2,4-dideoxyhexose or a 2,4,6-trideoxyhexose from a substituted or unsubstituted carbonyl compound with at least 2 carbon atoms and at least one &agr;-hydrogen atom and a substituted or unsubstituted aldehyde in the presence of an aldolase and water, the reaction between the substituted or unsubstituted carbonyl compound with at least 2 carbon atoms and at least one &agr;-hydrogen atom and the substituted or unsubstituted aldehyde being carried out at a carbonyl concentration of at most 6 moles/l of reaction mixture and the final concentration of the 2,4-dideoxyhexose or the 2,4,6-trideoxyhexose being at least 2 mass % of the reaction mixture. The invention also relates to the use of a 2,4-dideoxyhexose or a 2,4,6-trideoxyhexose obtained by means of a process according to the invention in the preparation of a medicine, particularly in the preparation of a statine.
本发明涉及一种在醛缩酶和水的存在下,由具有至少 2 个碳原子和至少 1 个&agr;-氢原子的取代或未取代羰基化合物和取代或未取代醛制备 2,4-二脱氧己糖或 2,4,6-三脱氧己糖的工艺,具有至少 2 个碳原子和至少 1 个&agr;-氢原子的取代或未取代羰基化合物和取代或未取代醛之间的反应在羰基浓度最多为 6 摩尔/升的反应混合物中进行,最终浓度为 2,4-二脱氧己糖或 2,4,6-三脱氧己糖;-氢原子的取代或未取代的羰基化合物与取代或未取代的醛之间的反应是在羰基浓度为至多 6 摩尔/升的反应混合物中进行的,2,4-二脱氧己糖或 2,4,6-三脱氧己糖的最终浓度至少为反应混合物的 2 质量%。本发明还涉及将通过本发明工艺获得的 2,4-二脱氧己糖或 2,4,6-三脱氧己糖用于制备药物,特别是制备他汀类药物。